Compare FEIM & OFIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FEIM | OFIX |
|---|---|---|
| Founded | 1961 | 1987 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Electrical Products | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 439.6M | 473.3M |
| IPO Year | 1994 | 1998 |
| Metric | FEIM | OFIX |
|---|---|---|
| Price | $48.95 | $11.49 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 2 | 5 |
| Target Price | ★ $42.50 | $17.25 |
| AVG Volume (30 Days) | 188.0K | ★ 247.1K |
| Earning Date | 03-11-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 316.95 | 29.39 |
| EPS | ★ 0.41 | N/A |
| Revenue | $69,811,000.00 | ★ $822,312,000.00 |
| Revenue This Year | N/A | $6.15 |
| Revenue Next Year | $21.73 | $6.24 |
| P/E Ratio | $113.95 | ★ N/A |
| Revenue Growth | ★ 26.30 | 2.85 |
| 52 Week Low | $14.41 | $10.25 |
| 52 Week High | $61.47 | $16.99 |
| Indicator | FEIM | OFIX |
|---|---|---|
| Relative Strength Index (RSI) | 53.65 | 37.40 |
| Support Level | $47.54 | $10.75 |
| Resistance Level | $59.68 | $11.58 |
| Average True Range (ATR) | 3.39 | 0.39 |
| MACD | 0.43 | 0.02 |
| Stochastic Oscillator | 88.79 | 33.91 |
Frequency Electronics Inc is engaged in the design, development, and manufacture of high-precision timing, and frequency control products for space, air, sea, and terrestrial applications. The company has FEI-NY and FEI-Zyfer reportable segments. It derives the majority of its revenues from the FEI-NY segment. FEI-NY segment operations consist principally of precision time and frequency control products used in three principal markets namely communication satellites (both commercial and U.S. Government-funded); terrestrial cellular telephone or other ground-based telecommunication stations; and other components and systems for the U.S. military.
Orthofix Medical Inc. is a medical device company delivering orthopedic and spine solutions to healthcare providers. The company has two reportable segments: Global Spine and Global Limb Reconstruction. The Global Spine segment offers bone growth therapies, spinal implants, biologics, and enabling technologies used in spinal procedures. The Global Limb Reconstruction segment provides products and solutions for limb deformity correction, limb lengthening, fracture management, and limb preservation, supported by digital technologies. It generates the majority of its revenue from the Global Spine segment.